Richard Judson, Ph.D.

Richard Judson, Ph.D.

National Center for Computational Toxicology 

Office of Research and Development

Alternative Approaches to Chemical Risk Assessment: Assays, Databases, Models
Date: Wednesday, March 29th 
Time: 12 to 1 p.m.
Place: B448 Life Science Bldg 

This talk will discuss approaches we are developing to perform risk assessments on data-poor chemicals, including the use of in vitro pathway and toxicokinetics assays, the development of large databases of in vitro, in vivo and exposure data to be used for development and validation of in vitro to in vivo and read-across models. Examples will focus on applications to important EPA public health programs – the Superfund and Endocrine Disruptor Screening Programs.


  • This abstract does not necessarily represent U.S. EPA policy.
excerpted from the EPA website: 
Dr. Judson is with the EPA National Center for Computational Toxicology where he is developing databases and computer applications to predict and model toxicological effects of a wide range of chemicals. Prior to joining the EPA, Dr. Judson was founder of GAMA BioConsulting, where he developed methods for genome-wide association analyses. He was also President and co-founder of SpyroPharma, an anti-viral drug development company. From 1999-2006, he was with Genaissance Pharmaceuticals, where he was Senior Vice President and Chief Scientific Officer. He was group leader in bioinformatics as Curagen from 1997-1998 and Senior Member of the Technical Staff at Sandia National Laboratories from 1990-1996. He is widely published in a variety of areas including genomics, physics, chemistry and applied math, and is an inventor on several issued patents. Dr. Judson has a BA in Chemistry and Chemical Physics from Rice University and an MA and PhD in Chemistry from Princeton University.